Nathan Judson McDannold, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 56 | 2024 | 1018 | 11.310 |
Why?
|
| Microbubbles | 37 | 2024 | 128 | 7.670 |
Why?
|
| Ultrasonic Therapy | 43 | 2020 | 215 | 7.070 |
Why?
|
| Sonication | 27 | 2024 | 79 | 6.580 |
Why?
|
| Drug Delivery Systems | 29 | 2024 | 2211 | 3.290 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 11 | 2023 | 40 | 3.030 |
Why?
|
| Essential Tremor | 9 | 2023 | 157 | 2.340 |
Why?
|
| Magnetic Resonance Imaging | 93 | 2024 | 36285 | 2.240 |
Why?
|
| Ultrasonics | 15 | 2020 | 206 | 2.180 |
Why?
|
| Ultrasonography | 25 | 2023 | 5952 | 2.120 |
Why?
|
| Acoustics | 14 | 2024 | 242 | 2.070 |
Why?
|
| Doxorubicin | 10 | 2018 | 2209 | 2.050 |
Why?
|
| Capillary Permeability | 8 | 2019 | 769 | 1.770 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 8 | 2015 | 187 | 1.650 |
Why?
|
| Brain Neoplasms | 18 | 2024 | 8981 | 1.550 |
Why?
|
| Antibiotics, Antineoplastic | 5 | 2017 | 675 | 1.540 |
Why?
|
| Phantoms, Imaging | 17 | 2024 | 2509 | 1.530 |
Why?
|
| Fluorocarbons | 13 | 2019 | 489 | 1.520 |
Why?
|
| Skull | 9 | 2022 | 815 | 1.450 |
Why?
|
| Brain | 49 | 2024 | 26951 | 1.350 |
Why?
|
| Contrast Media | 24 | 2019 | 5298 | 1.350 |
Why?
|
| Rats, Sprague-Dawley | 24 | 2024 | 8144 | 1.310 |
Why?
|
| Thermography | 4 | 2010 | 62 | 1.270 |
Why?
|
| Surgery, Computer-Assisted | 8 | 2020 | 1008 | 1.250 |
Why?
|
| Ultrasonography, Interventional | 10 | 2021 | 1489 | 1.250 |
Why?
|
| Transducers | 14 | 2024 | 240 | 1.240 |
Why?
|
| Rats | 30 | 2024 | 23681 | 1.160 |
Why?
|
| Albumins | 9 | 2016 | 575 | 1.150 |
Why?
|
| Glioma | 6 | 2024 | 3418 | 1.060 |
Why?
|
| Gliosarcoma | 3 | 2016 | 113 | 1.060 |
Why?
|
| Leiomyoma | 10 | 2009 | 654 | 0.960 |
Why?
|
| Temperature | 15 | 2020 | 2219 | 0.950 |
Why?
|
| Hyperthermia, Induced | 8 | 2016 | 416 | 0.910 |
Why?
|
| Holography | 1 | 2024 | 79 | 0.910 |
Why?
|
| Thalamus | 7 | 2023 | 1040 | 0.900 |
Why?
|
| Rabbits | 36 | 2018 | 4771 | 0.860 |
Why?
|
| Ablation Techniques | 2 | 2016 | 248 | 0.850 |
Why?
|
| Body Temperature | 10 | 2011 | 777 | 0.830 |
Why?
|
| Animals | 102 | 2024 | 167777 | 0.810 |
Why?
|
| Neurosurgical Procedures | 7 | 2022 | 2055 | 0.770 |
Why?
|
| Thermometers | 8 | 2011 | 42 | 0.740 |
Why?
|
| Uterine Neoplasms | 10 | 2009 | 1439 | 0.730 |
Why?
|
| Echoencephalography | 3 | 2013 | 134 | 0.730 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2020 | 70 | 0.690 |
Why?
|
| Gadolinium DTPA | 11 | 2016 | 823 | 0.690 |
Why?
|
| Macaca mulatta | 10 | 2018 | 2316 | 0.660 |
Why?
|
| Somatosensory Cortex | 3 | 2020 | 511 | 0.640 |
Why?
|
| Cerebrovascular Circulation | 5 | 2019 | 2731 | 0.610 |
Why?
|
| Antineoplastic Agents | 8 | 2020 | 13591 | 0.610 |
Why?
|
| Cranial Irradiation | 1 | 2020 | 390 | 0.580 |
Why?
|
| Carboplatin | 1 | 2019 | 788 | 0.530 |
Why?
|
| High-Energy Shock Waves | 1 | 2015 | 33 | 0.510 |
Why?
|
| Scalp | 1 | 2018 | 389 | 0.500 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2019 | 1132 | 0.490 |
Why?
|
| Neurotransmitter Agents | 1 | 2019 | 663 | 0.480 |
Why?
|
| Echo-Planar Imaging | 5 | 2011 | 657 | 0.470 |
Why?
|
| Neurosurgery | 1 | 2020 | 670 | 0.460 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 4048 | 0.440 |
Why?
|
| Blood-Retinal Barrier | 1 | 2012 | 62 | 0.410 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2012 | 75 | 0.390 |
Why?
|
| Glioblastoma | 2 | 2024 | 3480 | 0.370 |
Why?
|
| Pharmaceutical Preparations | 1 | 2019 | 1090 | 0.360 |
Why?
|
| Male | 63 | 2024 | 358742 | 0.350 |
Why?
|
| Therapy, Computer-Assisted | 3 | 2007 | 266 | 0.350 |
Why?
|
| Bone Marrow | 1 | 2020 | 2909 | 0.340 |
Why?
|
| Polyethylene Glycols | 4 | 2017 | 1188 | 0.330 |
Why?
|
| Hot Temperature | 6 | 2014 | 1434 | 0.330 |
Why?
|
| Visual Pathways | 1 | 2013 | 534 | 0.330 |
Why?
|
| Biometry | 1 | 2012 | 559 | 0.320 |
Why?
|
| Head | 1 | 2014 | 921 | 0.320 |
Why?
|
| Biological Transport | 5 | 2023 | 2084 | 0.310 |
Why?
|
| Brain Diseases | 4 | 2013 | 1541 | 0.300 |
Why?
|
| Models, Theoretical | 4 | 2016 | 3561 | 0.300 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2017 | 8946 | 0.300 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2007 | 19 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2017 | 3339 | 0.280 |
Why?
|
| Liposomes | 4 | 2019 | 777 | 0.280 |
Why?
|
| Nerve Net | 1 | 2018 | 2263 | 0.260 |
Why?
|
| Tremor | 4 | 2023 | 191 | 0.260 |
Why?
|
| Models, Animal | 7 | 2019 | 2112 | 0.260 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2019 | 281 | 0.250 |
Why?
|
| Oxygen | 1 | 2016 | 4192 | 0.240 |
Why?
|
| Rats, Nude | 2 | 2016 | 105 | 0.240 |
Why?
|
| Parkinson Disease | 3 | 2023 | 2862 | 0.240 |
Why?
|
| Protons | 2 | 2011 | 1112 | 0.240 |
Why?
|
| Emulsions | 4 | 2019 | 152 | 0.240 |
Why?
|
| Permeability | 3 | 2016 | 718 | 0.230 |
Why?
|
| Equipment Design | 8 | 2013 | 3507 | 0.220 |
Why?
|
| Muscles | 3 | 2011 | 1579 | 0.210 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 16886 | 0.210 |
Why?
|
| Hyperostosis | 1 | 2022 | 29 | 0.210 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2004 | 189 | 0.210 |
Why?
|
| Electroencephalography | 1 | 2018 | 6187 | 0.210 |
Why?
|
| Ceramides | 1 | 2024 | 200 | 0.210 |
Why?
|
| Nerve Block | 2 | 2020 | 688 | 0.210 |
Why?
|
| Nanotechnology | 3 | 2019 | 707 | 0.200 |
Why?
|
| Neoplasms, Experimental | 3 | 2018 | 1228 | 0.200 |
Why?
|
| Electric Stimulation | 2 | 2019 | 1732 | 0.200 |
Why?
|
| Receptors, Transferrin | 1 | 2023 | 291 | 0.200 |
Why?
|
| Image Enhancement | 2 | 2012 | 2880 | 0.200 |
Why?
|
| Neurons | 3 | 2020 | 9418 | 0.200 |
Why?
|
| Globus Pallidus | 1 | 2023 | 250 | 0.190 |
Why?
|
| Rats, Inbred F344 | 2 | 2020 | 825 | 0.190 |
Why?
|
| Skin Temperature | 1 | 2001 | 96 | 0.180 |
Why?
|
| Breast | 2 | 2007 | 1963 | 0.180 |
Why?
|
| Humans | 64 | 2024 | 758381 | 0.180 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2024 | 617 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2017 | 3758 | 0.180 |
Why?
|
| Computer Simulation | 5 | 2024 | 6201 | 0.170 |
Why?
|
| Anesthesia | 1 | 2011 | 1582 | 0.170 |
Why?
|
| Purpura | 1 | 2020 | 116 | 0.170 |
Why?
|
| Psychosurgery | 1 | 2019 | 86 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 5759 | 0.170 |
Why?
|
| Sound | 3 | 2022 | 257 | 0.160 |
Why?
|
| Electrodes | 2 | 2018 | 613 | 0.160 |
Why?
|
| Rhodamines | 1 | 2019 | 178 | 0.160 |
Why?
|
| Reproducibility of Results | 8 | 2020 | 20052 | 0.150 |
Why?
|
| Prodrugs | 1 | 2020 | 259 | 0.150 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 276 | 0.150 |
Why?
|
| Carbocyanines | 1 | 2017 | 175 | 0.140 |
Why?
|
| Equipment Failure Analysis | 2 | 2012 | 843 | 0.140 |
Why?
|
| Bupivacaine | 1 | 2020 | 413 | 0.140 |
Why?
|
| Feasibility Studies | 7 | 2015 | 5199 | 0.140 |
Why?
|
| Tetrodotoxin | 1 | 2018 | 246 | 0.140 |
Why?
|
| Muscle Neoplasms | 1 | 1998 | 133 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2006 | 2167 | 0.130 |
Why?
|
| Female | 29 | 2024 | 390316 | 0.130 |
Why?
|
| Hippocampus | 2 | 2020 | 3736 | 0.130 |
Why?
|
| Kidney | 3 | 2009 | 7016 | 0.130 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2020 | 388 | 0.130 |
Why?
|
| Brain Edema | 1 | 2020 | 603 | 0.130 |
Why?
|
| Random Allocation | 1 | 2020 | 2385 | 0.130 |
Why?
|
| Mice | 13 | 2023 | 81107 | 0.130 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 18125 | 0.130 |
Why?
|
| Luminescent Proteins | 1 | 2017 | 835 | 0.120 |
Why?
|
| Brain Mapping | 3 | 2019 | 6570 | 0.120 |
Why?
|
| In Situ Nick-End Labeling | 5 | 2006 | 609 | 0.120 |
Why?
|
| Radiation Dosage | 3 | 2015 | 1956 | 0.110 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2015 | 246 | 0.110 |
Why?
|
| Gadolinium | 1 | 2019 | 959 | 0.110 |
Why?
|
| Tissue Distribution | 2 | 2015 | 2263 | 0.110 |
Why?
|
| Gels | 2 | 2011 | 419 | 0.110 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 493 | 0.110 |
Why?
|
| Volatilization | 3 | 2019 | 79 | 0.110 |
Why?
|
| Rest | 1 | 2018 | 914 | 0.110 |
Why?
|
| Viscosity | 1 | 2013 | 335 | 0.110 |
Why?
|
| Alzheimer Disease | 3 | 2022 | 8544 | 0.110 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 961 | 0.100 |
Why?
|
| Skull Base | 1 | 2015 | 291 | 0.100 |
Why?
|
| Nanoparticles | 2 | 2023 | 1940 | 0.100 |
Why?
|
| Necrosis | 5 | 2017 | 1604 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 1647 | 0.100 |
Why?
|
| Nanocapsules | 1 | 2013 | 92 | 0.100 |
Why?
|
| Time Factors | 7 | 2019 | 39873 | 0.100 |
Why?
|
| Movement Disorders | 1 | 2015 | 459 | 0.100 |
Why?
|
| Geniculate Bodies | 1 | 2012 | 154 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2017 | 1233 | 0.090 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 1897 | 0.090 |
Why?
|
| Models, Biological | 3 | 2016 | 9461 | 0.090 |
Why?
|
| Catheter Ablation | 2 | 2004 | 2740 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2023 | 8554 | 0.090 |
Why?
|
| Muscle, Skeletal | 3 | 2001 | 4902 | 0.090 |
Why?
|
| Sensitivity and Specificity | 5 | 2012 | 14641 | 0.090 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 1270 | 0.090 |
Why?
|
| Radio Waves | 1 | 2011 | 250 | 0.090 |
Why?
|
| Rats, Wistar | 1 | 2013 | 1844 | 0.080 |
Why?
|
| Neurosciences | 1 | 2013 | 353 | 0.080 |
Why?
|
| Treatment Outcome | 14 | 2023 | 64379 | 0.080 |
Why?
|
| Calibration | 1 | 2011 | 814 | 0.080 |
Why?
|
| Epilepsy | 1 | 2023 | 3269 | 0.080 |
Why?
|
| Liver | 1 | 2004 | 7502 | 0.080 |
Why?
|
| Tight Junctions | 2 | 2008 | 317 | 0.080 |
Why?
|
| Silicon | 1 | 2008 | 142 | 0.070 |
Why?
|
| Algorithms | 5 | 2017 | 13959 | 0.070 |
Why?
|
| Plaque, Amyloid | 2 | 2022 | 758 | 0.070 |
Why?
|
| Neoplasm Transplantation | 2 | 2004 | 2013 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2018 | 3040 | 0.070 |
Why?
|
| Least-Squares Analysis | 1 | 2008 | 369 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 4 | 2008 | 9160 | 0.070 |
Why?
|
| Feedback | 1 | 2010 | 791 | 0.070 |
Why?
|
| Water | 2 | 2011 | 1402 | 0.070 |
Why?
|
| Apoptosis | 5 | 2006 | 9468 | 0.070 |
Why?
|
| Cattle | 2 | 2011 | 3846 | 0.070 |
Why?
|
| Elasticity | 1 | 2008 | 652 | 0.070 |
Why?
|
| Gyrus Cinguli | 1 | 2012 | 1115 | 0.070 |
Why?
|
| Middle Aged | 11 | 2024 | 219560 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2796 | 0.070 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2553 | 0.060 |
Why?
|
| Arterioles | 1 | 2006 | 250 | 0.060 |
Why?
|
| Thigh | 3 | 2004 | 240 | 0.060 |
Why?
|
| Visual Fields | 1 | 2012 | 1054 | 0.060 |
Why?
|
| Neoplasms | 3 | 2014 | 22030 | 0.060 |
Why?
|
| Differential Threshold | 1 | 2004 | 80 | 0.060 |
Why?
|
| Movement | 1 | 2011 | 1474 | 0.060 |
Why?
|
| Adult | 10 | 2024 | 219916 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 881 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2024 | 80170 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2017 | 4426 | 0.060 |
Why?
|
| Drug Stability | 1 | 2004 | 290 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 714 | 0.060 |
Why?
|
| Aged | 7 | 2024 | 168217 | 0.050 |
Why?
|
| Transgenes | 2 | 2023 | 1007 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 1489 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2017 | 3220 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11070 | 0.050 |
Why?
|
| Menstrual Cycle | 1 | 2006 | 536 | 0.050 |
Why?
|
| Dyskinesias | 1 | 2023 | 79 | 0.050 |
Why?
|
| Breast Neoplasms | 5 | 2018 | 21017 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2009 | 1112 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2023 | 6209 | 0.050 |
Why?
|
| Magnetics | 2 | 2017 | 600 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2023 | 471 | 0.050 |
Why?
|
| Cell Count | 1 | 2005 | 1835 | 0.050 |
Why?
|
| Retina | 1 | 2012 | 2637 | 0.050 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2021 | 65 | 0.050 |
Why?
|
| Fibroadenoma | 1 | 2001 | 41 | 0.050 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3533 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2009 | 2154 | 0.050 |
Why?
|
| Normal Distribution | 1 | 2001 | 272 | 0.040 |
Why?
|
| Electrocoagulation | 1 | 2000 | 152 | 0.040 |
Why?
|
| Follow-Up Studies | 6 | 2022 | 39060 | 0.040 |
Why?
|
| Vibrissae | 1 | 2020 | 116 | 0.040 |
Why?
|
| Radiometry | 1 | 2005 | 813 | 0.040 |
Why?
|
| Heating | 1 | 2000 | 101 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2001 | 271 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2009 | 2782 | 0.040 |
Why?
|
| Abdomen | 1 | 2005 | 1129 | 0.040 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 939 | 0.040 |
Why?
|
| Neuronavigation | 1 | 2020 | 164 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4690 | 0.040 |
Why?
|
| Hindlimb | 1 | 2000 | 508 | 0.040 |
Why?
|
| Heart | 1 | 2011 | 4382 | 0.040 |
Why?
|
| Maytansine | 1 | 2018 | 86 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11709 | 0.040 |
Why?
|
| Horseradish Peroxidase | 2 | 2008 | 166 | 0.040 |
Why?
|
| Prostate | 1 | 2005 | 1791 | 0.030 |
Why?
|
| Prospective Studies | 6 | 2023 | 54136 | 0.030 |
Why?
|
| Ligands | 1 | 2023 | 3258 | 0.030 |
Why?
|
| Wireless Technology | 1 | 2017 | 98 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2008 | 317 | 0.030 |
Why?
|
| ROC Curve | 1 | 2004 | 3563 | 0.030 |
Why?
|
| Immunity | 1 | 2022 | 998 | 0.030 |
Why?
|
| Linear Models | 1 | 2006 | 5861 | 0.030 |
Why?
|
| Artifacts | 2 | 2005 | 1897 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 4429 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2019 | 1570 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 1999 | 524 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10747 | 0.030 |
Why?
|
| Antibodies | 1 | 2023 | 2420 | 0.030 |
Why?
|
| Radiography | 1 | 2006 | 6955 | 0.030 |
Why?
|
| Cryosurgery | 1 | 2000 | 475 | 0.030 |
Why?
|
| Body Water | 2 | 2011 | 341 | 0.030 |
Why?
|
| Excipients | 1 | 2014 | 97 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2018 | 613 | 0.030 |
Why?
|
| Primates | 1 | 2016 | 523 | 0.030 |
Why?
|
| Swine | 1 | 2004 | 5892 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 4540 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2048 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9518 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2020 | 1000 | 0.030 |
Why?
|
| Acrylamides | 1 | 2014 | 259 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 2006 | 1378 | 0.030 |
Why?
|
| Microcirculation | 2 | 2008 | 1273 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2001 | 1659 | 0.030 |
Why?
|
| Coloring Agents | 2 | 2006 | 560 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2006 | 2557 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 2292 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2005 | 3047 | 0.020 |
Why?
|
| Forecasting | 1 | 2000 | 2920 | 0.020 |
Why?
|
| Cheese | 1 | 2011 | 38 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2003 | 2044 | 0.020 |
Why?
|
| Fats | 1 | 2011 | 99 | 0.020 |
Why?
|
| Body Temperature Regulation | 2 | 2003 | 286 | 0.020 |
Why?
|
| Craniotomy | 2 | 2005 | 741 | 0.020 |
Why?
|
| Particle Size | 1 | 2014 | 1641 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3574 | 0.020 |
Why?
|
| Mammography | 1 | 2001 | 2427 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 2497 | 0.020 |
Why?
|
| Cell Line | 1 | 2023 | 15594 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2011 | 428 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7199 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 308 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 4313 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2000 | 3299 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 4809 | 0.020 |
Why?
|
| Urination | 1 | 2009 | 202 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 3826 | 0.020 |
Why?
|
| Dextrans | 1 | 2009 | 573 | 0.020 |
Why?
|
| Vanadium Compounds | 1 | 2006 | 8 | 0.020 |
Why?
|
| Tolonium Chloride | 1 | 2006 | 23 | 0.020 |
Why?
|
| Polymers | 1 | 2014 | 1615 | 0.020 |
Why?
|
| Hematoxylin | 1 | 2006 | 60 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2006 | 48 | 0.020 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2006 | 69 | 0.020 |
Why?
|
| Utah | 1 | 2006 | 131 | 0.020 |
Why?
|
| Venules | 1 | 2006 | 164 | 0.020 |
Why?
|
| Diffusion | 1 | 2008 | 813 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 41252 | 0.020 |
Why?
|
| Fluorescence | 1 | 2008 | 749 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58681 | 0.020 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2005 | 170 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2006 | 348 | 0.020 |
Why?
|
| Photomicrography | 1 | 2004 | 71 | 0.010 |
Why?
|
| Quality of Life | 2 | 2022 | 13286 | 0.010 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2005 | 101 | 0.010 |
Why?
|
| Cell Survival | 1 | 2014 | 5781 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 7985 | 0.010 |
Why?
|
| Creatinine | 1 | 2009 | 1892 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2009 | 907 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 2005 | 488 | 0.010 |
Why?
|
| Motor Cortex | 1 | 2011 | 997 | 0.010 |
Why?
|
| Capillaries | 1 | 2006 | 744 | 0.010 |
Why?
|
| Trypan Blue | 1 | 2003 | 22 | 0.010 |
Why?
|
| Visual Cortex | 1 | 2011 | 1089 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 58808 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 397 | 0.010 |
Why?
|
| Models, Statistical | 2 | 2011 | 5070 | 0.010 |
Why?
|
| Premenopause | 1 | 2006 | 1038 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2005 | 837 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 1433 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2002 | 512 | 0.010 |
Why?
|
| Nanostructures | 1 | 2006 | 547 | 0.010 |
Why?
|
| Radiation Protection | 1 | 2005 | 425 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2005 | 1084 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6233 | 0.010 |
Why?
|
| Posture | 1 | 2004 | 953 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 3838 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 1203 | 0.010 |
Why?
|
| Cadaver | 1 | 2004 | 1345 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2000 | 530 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20500 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22006 | 0.010 |
Why?
|
| United States | 1 | 2006 | 72140 | 0.010 |
Why?
|
| Mathematics | 1 | 1998 | 707 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29558 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2002 | 1184 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 3380 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7843 | 0.010 |
Why?
|
| DNA Damage | 1 | 2001 | 2439 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2005 | 4641 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 1999 | 1263 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 11894 | 0.000 |
Why?
|